Malignant hypercalcaemia in pregnancy and antenatal administration of intravenous pamidronate.
A patient is reported who was found to have metastatic breast cancer in pregnancy. Intravenous pamidronate was given with beneficial effect in the third trimester. There were no serious adverse effects on the foetus.
Illidge
T M
TM
Wessex Radiotherapy Centre, Southampton, UK.
Hussey
M
M
Godden
C W
CW
D000328:Adult; D001943:Breast Neoplasms / Q000150:complications / Q000556:secondary*; D004164:Diphosphonates / Q000627:therapeutic use*; D017809:Fatal Outcome; D005260:Female; D006801:Humans; D006934:Hypercalcemia / Q000150:complications / Q000188:drug therapy*; D007231:Infant, Newborn; D007415:Intestinal Obstruction / Q000150:complications; D008297:Male; D000077268:Pamidronate; D011247:Pregnancy; D011252:Pregnancy Complications, Neoplastic / Q000473:pathology*; D012127:Respiratory Distress Syndrome, Newborn / Q000628:therapy
D004164:Diphosphonates; D000077268:Pamidronate